Montelukast induced down-regulation of Bcl-2, up-regulation of Bcl-2 homologous antagonist/killer, and nuclear translocation of apoptosis-inducing factors in lung cancer cells (27). The gene discussed is BCL2; the disease is lung carcinoma.